Acemoglu, D. and Linn, J. (2004). Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry. The Quarterly Journal of Economics, 119(3):1049–1090.
Adner, R. and Levinthal, D. (2001). Demand Heterogeneity and Technology Evolution: Implications for Product and Process Innovation. Management Science, 47(5):611–628.
- Andersen, B. (1998). The Evolution of Technological Trajectories 1890–1990. Structural Change and Economic Dynamics, 9(1):5–34.
Paper not yet in RePEc: Add citation now
Andersen, B. (1999). The Hunt for S-shaped Growth Paths in Technological Innovation: A Patent Study. Journal of Evolutionary Economics, 9(4):487–526.
Becker, W. and Peters, J. (2000). Technological Opportunities, Absorptive Capacities, and Innovation. Discussion Paper Series, University of Augsburg, Institute for Economics, 195.
Bitzer, J. and Stephan, A. (2007). A Schumpeter-inspired Approach to the Construction of R&D Capital Stocks. Applied Economics, 39(2):179–189.
Blundell, R., Griffith, R., and Reenen, J. V. (1995). Dynamic Count Data Models of Technological Innovation. The Economic Journal, 105(429):333–344.
Blundell, R., Griffith, R., and Windmeijer, F. (2002). Individual Effects and Dynamics in Count Data Models. Journal of Econometrics, 108(1):113–131.
Castellacci, F. (2007). Technological Regimes and Sectoral Differences in Productivity Growth. Industrial and Corporate Change, 16(6):1105–1145.
Cerda, R. A. (2007). Endogenous Innovations in the Pharmaceutical Industry. Journal of Evolutionary Economics, 17(4):473–515.
Cockburn, I. M. and Henderson, R. M. (2001). Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research. Journal of Health Economics, 20(6):1033–1057.
Cohen, W. M. and Levin, R. C. (1989). Empirical Studies of Innovation and Market Structure.
Cohen, W. M. and Levinthal, D. A. (1989). Innovation and Learning: The Two Faces of R & D. The Economic Journal, 99(397):569–596.
Cohen, W., Nelson, R., and Walsh, J. (2002). Links and Impacts: The Influence of Public Research on Industrial R&D. Management Science, 48(1):1–23.
- DiMasi, J. A. and Grabowski, H. G. (2007). The Cost of Biopharmaceutical R&D: Is Biotech Different? Managerial and Decision Economics, 28(4-5):469–479.
Paper not yet in RePEc: Add citation now
- Dosi, G. (1988). Sources, Procedures, and Microeconomic Effects of Innovation. Journal of Economic Literature, 26(3):1120–1171.
Paper not yet in RePEc: Add citation now
Freeman, C. (1994). The Economics of Technical Change. Cambridge Journal of Economics, 18(5):463–514.
Galambos, L. and Sturchio, J. L. (1998). Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation. The Business History Review, 72(2):250–278.
Gambardella, A. (1995). Science and Innovation: The U.S. Pharmaceutical Industry During the 1980s. Cambridge University Press, Cambridge et al.
Geroski, P. A. and Walters, C. F. (1995). Innovative Activity over the Business Cycle. The Economic Journal, 105(431):916–928.
Giaccotto, C., Santerre, R. E., and Vernon, J. A. (2005). Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry. Journal of Law and Economics, 48(1):195–214.
Gourieroux, C., Monfort, A., and Trognon, A. (1984). Pseudo Maximum Likelihood Methods: Applications to Poisson Models. Econometrica, 52(3):701–720.
Grabowski, H. and Vernon, J. (2000). The Determinants of Pharmaceutical Research and Development Expenditures. Journal of Evolutionary Economics, 10(1-2):201–215.
Grabowski, H. G. (1968). The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries. Journal of Political Economy, 76(2):292–306.
- Grabowski, H. G. and Wang, Y. R. (2006). The Quantity and Quality of Worldwide New Drug Introductions 19822003. Health Affairs, 25(2):452–460.
Paper not yet in RePEc: Add citation now
Grabowski, H. G., Vernon, J. M., and Thomas, L. G. (1978). Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry. Journal of Law and Economics, 21(1):133–163.
- Griliches, Z., Hall, B. H., and Pakes, A. (1991). R&D, Patents, and Market Value Revisited: Is There A Second (Technological Opportunity) Factor? Economics of Innovation & New Technology, 1(3):183–201.
Paper not yet in RePEc: Add citation now
- Hamilton, K. S. (2003). Subï¬eld and Level Classiï¬cation of Journals. CHI Research Inc., CHI No. 2012-R.
Paper not yet in RePEc: Add citation now
Henderson, R. and Cockburn, I. (1994). Measuring Competence? Exploring Firm Effects in Pharmaceutical Research. Strategic Management Journal, 15:63–84.
- In Schmalensee, R. and Willig, R., editors, Handbook of Industrial Organization, pages 1059–1107. Elsevier, Amsterdam et al.
Paper not yet in RePEc: Add citation now
- Jaffe, A. B. (1986). Technological Opportunity and Spillovers of R&D: Evidence from Firms’ Patents, Proï¬ts, and Market Value. The American Economic Review, 76(5):984– 1001.
Paper not yet in RePEc: Add citation now
- Jaffe, A. B. (1989a). Characterizing the ’Technological Position’ of Firms, with Application to Quantifying Technological Opportunity and Research Spillovers. Research Policy, 18(2):8–97.
Paper not yet in RePEc: Add citation now
- Kleinknecht, A. and Verspagen, B. (1990). Demand and Innovation: Schmookler Reexamined. Research Policy, 19(4):387–394.
Paper not yet in RePEc: Add citation now
- Klevorick, A. K., Levin, R. C., Nelson, R. R., and Winter, S. G. (1995). On the Sources and Signiï¬cance of Interindustry Differences in Technological Opportunities. Research Policy, 24(2):185–205.
Paper not yet in RePEc: Add citation now
Kremer, M. (2002). Pharmaceuticals and the Developing World. Journal of Economic Perspectives, Vol. 16(4):67–90.
- Lacy, C., Armstrong, L., Goldman, M., and Lance, L., editors (2010). Drug Information Handbook. Lexi-Comp, Hudson, 19th edition.
Paper not yet in RePEc: Add citation now
Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., and Griliches, Z. (1987). Appropriating the Returns from Industrial Research and Development. Brookings Papers on Economic Activity, 1987(3):783–831.
- Lichtenberg, F. R. (2004). Sources of U.S. Longevity Increase, 1960–2001. The Quarterly Review of Economics and Finance, 44(3):369–389.
Paper not yet in RePEc: Add citation now
- Lichtenberg, F. R. (2005a). Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries. Journal of Medicine and Philosophy, 30(6):663– 690.
Paper not yet in RePEc: Add citation now
- Lichtenberg, F. R. (2005b). The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001. International Journal of Health Care Finance and Economics, 5(1):47–73.
Paper not yet in RePEc: Add citation now
Lim, K. (2004). The Relationship Between Research and Innovation in the Semiconductor and Pharmaceutical Industries (1981-1997). Research Policy, 33(2):287–321.
Mahlich, J. C. and Roediger-Schluga, T. (2006). The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan. Review of Industrial Organization, 28(2):145–164.
Malerba, F., Nelson, R., Orsenigo, L., and Winter, S. (2007). Demand, Innovation, and the Dynamics of Market Structure: The Role of Experimental Users and Diverse Preferences. Journal of Evolutionary Economics, 17(4):371–399.
- McKelvey, M. (1996). Evolutionary Innovations: The Business of Biotechnology. Oxford University Press, Oxford et al.
Paper not yet in RePEc: Add citation now
Morton, F. M. S. (1999). Entry Decisions in the Generic Pharmaceutical Industry. The RAND Journal of Economics, 30(3):421–440.
Mowery, D. and Rosenberg, N. (1979). The Influence of Market Demand upon Innovation: A Critical Review of Some Recent Empirical Studies. Research Policy, 8(2):102 – 153.
Nelson, R. R. (1988). Modelling the Connections in the Cross Section between Technical Progress and R&D Intensity. The RAND Journal of Economics, 19(3):478–485.
- Nelson, R. R. and Wolff, E. N. (1997). Factors Behind Cross-Industry Differences in Technical Progress. Structural Change and Economic Dynamics, 8(2):205–220.
Paper not yet in RePEc: Add citation now
- Pan, W. (2001). Akaike’s Information Criterion in Generalized Estimating Equations. Biometrics, 57(1):120–125.
Paper not yet in RePEc: Add citation now
Rasmussen, B. (2010). Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value. Edward Elgar Publishing Ltd, Cheltenham and Northhampton.
Reiffen, D. and Ward, M. R. (2005). Generic Drug Industry Dynamics. Review of Economics and Statistics, 87(1):37–49.
- Scherer, F. M. (1965). Firm Size, Market Structure, Opportunity, and the Output of Patented Inventions. The American Economic Review, 55(5):1097–1125.
Paper not yet in RePEc: Add citation now
Scherer, F. M. (1982). Demand-pull and Technological Invention: Schmookler Revisited. The Journal of Industrial Economics, 30(3):225–237.
- Schmookler, J. (1966). Invention and Economic Growth. Harvard University Press, Cambridge.
Paper not yet in RePEc: Add citation now
Toole, A. (2007). Does Public Scientiï¬c Research Complement Private Investment in Research and Development in the Pharmaceutical Industry? The Journal of Law and Economics, 50(1):81–104.
Toole, A. A. (2012). The Impact of Public Basic Research on Industrial Innovation: Evidence from the Pharmaceutical Industry. Research Policy, 41(1):1–12.
- von Hippel, E. (1976). The Dominant Role of Users in the Scientiï¬c Instrument Innovation Process. Research Policy, 5(3):212–239.
Paper not yet in RePEc: Add citation now
Walsh, V. (1984). Invention and Innovation in the Chemical Industry: Demand-pull or Discovery-push? Research Policy, 13(4):211–234.
Yin, W. (2008). Market Incentives and Pharmaceutical Innovation. Journal of Health Economics, 27(4):1060–1077.